Candel Therapeutics to Present at TD Cowen's 46th Annual Health Care Conference in BostonGlobeNewsWire • 02/24/26
Stock Market Today: Dow Jones, S&P 500 Futures Rise Ahead Of Q4 GDP Numbers—Grail, Candel Therapeutics, Copart In FocusBenzinga • 02/20/26
Candel Therapeutics inks $100M funding agreement with RTW Investments, launches $100M public offeringProactive Investors • 02/19/26
Candel Therapeutics Announces $100M Royalty Funding Agreement with RTW to Support the Potential Launch of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate CancerGlobeNewsWire • 02/19/26
Candel Therapeutics to Present at the 7th Annual Glioblastoma Drug Development SummitGlobeNewsWire • 02/11/26
Candel Therapeutics highlights third quarter milestones across cancer immunotherapy pipelineProactive Investors • 11/13/25
Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate HighlightsGlobeNewsWire • 11/13/25
Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid TumorsGlobeNewsWire • 11/04/25
Candel Therapeutics to Present at Jefferies Global Healthcare Conference in LondonGlobeNewsWire • 11/03/25
Candel Therapeutics strengthens Research Advisory Board with appointment of immunology expertProactive Investors • 10/16/25
Candel Therapeutics Appoints Leading Systems Immunology Expert Bali Pulendran, Ph.D., to Research Advisory BoardGlobeNewsWire • 10/16/25
Candel Therapeutics secures $130M loan to advance cancer therapy trialsProactive Investors • 10/14/25
Candel Therapeutics Enters into $130 Million Term Loan Facility with Trinity Capital Inc.GlobeNewsWire • 10/14/25
Trinity Capital Inc. Provides $130 Million in Growth Capital to Candel Therapeutics, Supporting Development of Viral Immunotherapies to Fight CancerPRNewsWire • 10/14/25
Candel Therapeutics Announces Positive Interim Data After Repeated Administration of CAN-3110 in Recurrent Glioblastoma and Announces Publication in Science Translational MedicineGlobeNewsWire • 10/14/25